Reza Zadno's Net Worth

$19.3 Million

Estimate Recalculated Nov 8, 2024 09:39PM EST

Who is Reza Zadno

Reza Zadno has an estimated net worth of $19.3 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, Invuity, Inc., PROCEPT BioRobotics Corp, and Carbylan Therapeutics, Inc..

SEC CIK

Reza Zadno's CIK is 0001632326

Past Insider Trading and Trends

2019 was Reza Zadno's most active year for acquiring shares with 8 total transactions. Reza Zadno's most active month to acquire stocks was the month of February. 2019 was Reza Zadno's most active year for disposing of shares, totalling 12 transactions. Reza Zadno's most active month to dispose stocks was the month of October. 2022 saw Reza Zadno paying a total of $1,154,986.56 for 118,896 shares, this is the most they've acquired in one year. In 2024 Reza Zadno cashed out on 38,054 shares for a total of $691,626.46, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVEDRO INC

President and CEO
Updated Nov 25, 2019
Form 4
-100.00%
-1.09M
Nov 25, 2019
Disposition
Nov 21
Form 4
-1.78%
-1.75K
$22.93
-$40.20K
Sep 05, 2019
96.91K
Options
Mar 01 - Sep 03
Form 4/A
16.82K
Sep 05, 2019
16.82K
Options
Feb 13
Form 4
81.53K
Jun 18, 2019
81.53K
Grant
Jun 14
Form 4
267.42K
Feb 19, 2019
267.42K
Grant
Feb 19
Form 4
16.82K
Feb 15, 2019
17.14K
Grant
Feb 13
Form 3
Feb 13, 2019
315.00
Showing 7 results

Invuity, Inc.

Investor
Updated May 05, 2017
Form 4
-31.25%
-4.00K
$9.16
-$36.65K
May 05, 2017
8.80K
Sale
May 03
Form 4
Jun 21, 2016
12.80K
Options
Jun 19
Form 4/A
28.90K
May 23, 2016
28.90K
Grant
May 19
Form 4
39.20K
May 23, 2016
39.20K
Grant
May 19
Form 3
Jun 11, 2015
Showing 5 results

PROCEPT BioRobotics Corp

President, CEO
Updated Oct 31, 2024
Form 4
-19.13%
-288.46K
$47.69
-$24.99M
Oct 31, 2024
1.22M
Sale
Oct 30
Form 4
$4.37
$102.63K
Aug 23, 2024
1.51M
Options
Jul 31
Form 4/A
45.23%
90.89K
Apr 19, 2024
291.84K
Grant
Mar 06
Form 4
-2.19%
-5.39K
$48.83
-$263.24K
Mar 20, 2024
241.32K
Sale
Mar 18
Form 4
46.58%
93.60K
$46.67
-$428.38K
Mar 07, 2024
294.56K
Grant
Mar 06
Form 4
$4.37
$22.50K
Oct 18, 2023
1.47M
Options
Oct 18
Form 4
$4.37
$87.38K
May 02, 2023
1.47M
Options
Apr 28
Form 4
$4.37
$87.50K
Apr 05, 2023
1.47M
Options
Apr 04
Form 4
-3.31%
-5.33K
$31.84
-$169.87K
Mar 17, 2023
155.79K
Sale
Mar 16
Form 4
194.18%
185.12K
Feb 21, 2023
280.46K
Grant
Feb 16
Form 4
212.22%
118.90K
$29.38
$1.15M
Apr 04, 2022
174.92K
Grant
Mar 31
Form 4
Sep 21, 2021
56.03K
Options
Sep 17
Form 3
Sep 14, 2021
52.63K
Showing 13 results

Carbylan Therapeutics, Inc.

Investor
Updated Aug 05, 2015
Form 4
15.75K
Aug 05, 2015
15.75K
Grant
Aug 03
Form 4
6.25K
Apr 27, 2015
6.25K
Grant
Apr 24
Form 3
Apr 08, 2015
Showing 3 results